Cargando…
Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in Cancer
Deregulated cellular apoptosis is a hallmark of cancer and chemotherapy resistance. The B-cell lymphoma 2 (BCL-2) protein family members are sentinel molecules that regulate the mitochondrial apoptosis machinery and arbitrate cell fate through a delicate balance between pro- and anti-apoptotic facto...
Autores principales: | Ngoi, Natalie Yan Li, Choong, Clarice, Lee, Joanne, Bellot, Gregory, Wong, Andrea LA, Goh, Boon Cher, Pervaiz, Shazib |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139457/ https://www.ncbi.nlm.nih.gov/pubmed/32131385 http://dx.doi.org/10.3390/cancers12030574 |
Ejemplares similares
-
Sustained IKKβ phosphorylation and NF-κB activation by superoxide-induced peroxynitrite-mediated nitrotyrosine modification of B56γ3 and PP2A inactivation
por: Yee, Yi Hui, et al.
Publicado: (2020) -
The redox-senescence axis and its therapeutic targeting
por: Ngoi, Natalie YL., et al.
Publicado: (2021) -
Editorial: The proceedings of mitochondria apoptosis and cancer (MAC 2021) virtual symposium
por: Pervaiz, Shazib
Publicado: (2023) -
Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance
por: Hirpara, Jayshree, et al.
Publicado: (2018) -
A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer
por: Sooi, Kenneth, et al.
Publicado: (2023)